# PRR32

## Overview
PRR32 is a gene that encodes the proline-rich protein 32, which is characterized by its abundance of proline residues. This protein is implicated in various cellular processes, although its precise biological functions are not yet fully elucidated. The proline-rich nature of the protein suggests potential roles in protein-protein interactions, possibly influencing cellular signaling pathways. Research has linked PRR32 to several health conditions, including cardiac diseases, cognitive dysfunction in type 2 diabetes, and tooth agenesis, highlighting its potential clinical significance (Salvi2016Mutation; Ahn2020Integrative; Ci2018Expression). Further studies are required to understand the molecular mechanisms and pathways involving PRR32, which may provide insights into its role in disease pathogenesis and therapeutic potential.

## Structure


## Function


## Clinical Significance
The PRR32 gene has been implicated in several health conditions, although its precise role remains under investigation. In the context of cardiac health, PRR32 is identified as an atrial appendage-specific gene that may be involved in heart diseases such as cardiac fibrosis, hypertrophy, and necrosis. However, the specific pathways and mechanisms through which PRR32 influences these conditions are not yet fully understood (Ahn2020Integrative). 

In type 2 diabetes, PRR32 has been associated with cognitive dysfunction. A study found altered expression of PRR32 in the hippocampus of diabetic mice, suggesting a potential role in the pathology of cognitive impairments linked to diabetes (Ci2018Expression).

PRR32 has also been studied in the context of tooth agenesis. Genetic analysis identified mutations in PRR32 among other genes in individuals with this condition, indicating a possible involvement in its pathogenesis, although the clinical significance of these findings is not fully detailed (Salvi2016Mutation).

Overall, while PRR32 is associated with various conditions, further research is needed to clarify its clinical significance and potential as a therapeutic target.


## References


[1. (Salvi2016Mutation) Alessandro Salvi, Edoardo Giacopuzzi, Elena Bardellini, Francesca Amadori, Lia Ferrari, Giuseppina De Petro, Giuseppe Borsani, and Alessandra Majorana. Mutation analysis by direct and whole exome sequencing in familial and sporadic tooth agenesis. International Journal of Molecular Medicine, 38(5):1338–1348, September 2016. URL: http://dx.doi.org/10.3892/ijmm.2016.2742, doi:10.3892/ijmm.2016.2742. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ijmm.2016.2742)

[2. (Ahn2020Integrative) Jinsoo Ahn, Huiguang Wu, and Kichoon Lee. Integrative analysis revealing human heart-specific genes and consolidating heart-related phenotypes. Frontiers in Genetics, July 2020. URL: http://dx.doi.org/10.3389/fgene.2020.00777, doi:10.3389/fgene.2020.00777. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2020.00777)

[3. (Ci2018Expression) Li‑Ya Ci, De‑Shan Liu, Jing‑Qing Yang, Yu Liu, Chang Li, Xi Zhang, Chun Ma, and Rui Hu. Expression of long non‑coding rna and mrna in the hippocampus of mice with type 2 diabetes. Molecular Medicine Reports, September 2018. URL: http://dx.doi.org/10.3892/mmr.2018.9504, doi:10.3892/mmr.2018.9504. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2018.9504)